Eczema affects more people in the United States than diabetes (10.1 vs. 9.4 million)1,2. More than […]
Business as usual is not an option for conducting #clinicaltrials in the wake of the #COVID19 pandemic. Customized solutions and #patientcentricity are more optimal approaches in this environment. Jimmy El Hokayem, Ph.D., Associate Director of Program Development and Head of the Neurology and Regenerative Medicine Center of Excellence at Biorasi, shares his insights into #directtopatienttrials
Dermatology Detectives: How the Right Principal Investigator can Increase Patient Trust and Compliance
The success of a clinical trial depends largely on the engagement and experience of the PI. In addition to identifying and recruiting patients, site PIs and their teams conduct study procedures, complete study documentation, and retain patients for outcome assessments.
A Modern Approach to Patient Education Increases Enrollment
CNS trials especially can become mired down and derailed by a too-low enrollment rate, and the culprit is usually poor venue and site planning and selection. Patient Enrollment Needs To Be Strategic, Not Just Tactical. Learn more in this case study